Mack Trucks Inc. and Ford Motor Co. won a new trial in an asbestos exposure suit after Maryland’s top court threw out a Baltimore man’s $6 million jury award.
The trial court improperly instructed the jury on what is needed to show the companies negligently exposed him to asbestos-containing brake parts that he worked around.
The elements of … [Read more...]

The gadolinium contrast agents safety warnings announced by the FDA in December 2017 started to be seen on new drug labels approved in the spring of 2018.
It is important to understand that symptoms of gadolinium-related medical conditions can first appear anywhere from just a few hours until several weeks after the MRI or MRA procedure when a … [Read more...]

A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her exposure to cancer-causing asbestos began in South Carolina on Monday in the latest case against the healthcare conglomerate and a supplier over their talc-based products.
The case also names as a defendant a local unit of … [Read more...]

A person who received an injection of a gadolinium-based contrast agent (GBCA) may develop some medical conditions following their MRI or MRA procedure which could be symptoms of gadolinium deposition disease.
These various gadolinium-related symptoms include:
Persistent headache;
“Brain fog”;
Skin that appears spongy or rubbery, … [Read more...]

Arizona companies have no duty to protect family members from exposure to toxic materials their employees bring home on their work clothes, the Arizona Supreme Court ruled Friday.
In the first ruling of its kind in Arizona, a majority of the justices rejected arguments by of survivors of Ernest Quiroz that Reynolds Metal Co. should be held … [Read more...]

Background
In May 2016, the U.S. Food and Drug Administration (FDA) released a Drug Safety Communication concerning the antipsychotic drugs, Abilify, Abilify Maintena, and Aristada.
This safety announcement provided the following warning:
The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, … [Read more...]

Background
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a type of non-Hodgkin's lymphoma, which is a cancer of the cells of the immune system. This rare T-cell lymphoma can develop as a result of breast implants, though the mechanism of injury is not fully understood at this time. However, based on current data from the … [Read more...]

Some medical researchers recently took a look at reports submitted to FDA Adverse Event Reporting System (FAERS) from 2006 to 2015 for the purpose of reviewing the dipeptidyl peptidase-4 (DPP-4) inhibitor class of diabetes drugs side effects.An article which presented their findings, “Cardiovascular safety signals with dipeptidyl peptidase‐4 … [Read more...]

DPP-4 Diabetes DrugsOne of the popular classes of drugs for type 2 diabetes consists of dipeptidyl peptidase-4 (DPP-4) inhibitors.This DPP-4 inhibitors class comprises the following drugs:OnglyzaKombiglyze XRNesinaKazanoOseniGlyxambiJanumet (XR)JanuviaJentaduetoTradjentaQternBased on various studies and patient reports, these drugs have been … [Read more...]

Attorney Tom Lamb

Mr. Lamb is recognized by other lawyers as practicing law at the highest level of professional experience in terms of legal ability and ethical standards — which is indicated by an AV® Preeminent™ 5.0 out of 5 rating (highest classification) rating from the Martindale-Hubbell® Lawyer Directory.

More importantly, he received the Martindale-Hubbell® Client Distinction Award, which recognizes excellence for: